ViroPharma Inc. (VPHM) is in the Pharma Industry

• Sort by

• ViroPharma Incorporated Q1 2008 Earnings Call Transcript

  ViroPharma Incorporated Q1 2008 Earnings Call Transcript

  Earnings calls 2008-05-28

  Tags: ViroPharma Inc., Call Transcript, Earnings, Seeking Alpha, Financial Accounting, Finance

• ViroPharma Incorporated Q4 2007 Earnings Call Transcript

  ViroPharma Incorporated Q4 2007 Earnings Call Transcript

  Earnings calls 2008-03-10

  Tags: Call Transcript, Earnings, Seeking Alpha, Financial Accounting, Finance, ViroPharma Inc.

Additional Resources

• Zacks Bull and Bear of the Day Highlights: ViroPharma, Cooper Tire & Rubber, Tesoro Corp., Sonic Foundry and Shutterfly

  CHICAGO -- Zacks Equity Research highlights ViroPharma (Nasdaq: VPHM) as the Bull of the Day and Cooper Tire & Rubber (NYSE: CTB) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Tesoro Corp. (NYSE: TSO), Sonic Foundry (Nasdaq: SOFO) and Shutterfly, Inc. (Nasdaq: SFLY). ...

  Articles 2008-08-04

• Zacks Analyst Blog Highlights: State Auto Financial Corp., Kirkland's, Inc., ViroPharma, Inc., MetLife Inc. and Akamai Technologies, Inc

  CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: State Auto Financial Corp. (Nasdaq: STFC), Kirkland's, Inc. (Nasdaq: KIRK), ViroPharma,...

  Articles 2008-08-04

• Lev Reports Second Quarter 2008 Financial Results

  NEW YORK -- Lev Pharmaceuticals, Inc. ("Lev") (OTCBB: LEVP) today announced financial results for the three and six months ended June 30, 2008. Highlights and Current Developments: * Lev entered into a plan of merger with ViroPharma on July 15, 2008 for a potential net aggregate...

  Articles 2008-08-01

• ViroPharma Incorporated Reports Second Quarter 2008 Financial Results

  - Company Achieves Record VancocinR Net Sales; Increases Full Year Guidance for 2008 - EXTON, Pa., July 30 /PRNewswire-FirstCall/ -- ViroPharma Incorporated reported today its financial results for the second quarter and six-months ended June 30, 2008. Key events since March 31, 2008 include:...

  Articles 2008-07-30

• ViroPharma Inc. to Acquire Development Stage Lev Pharmaceuticals

  The Deal: ViroPharma Inc. has signed a definitive agreement to acquire Lev Pharmaceuticals for $442.9 million. Under the terms of the agreement, each share of Lev will be exchanged for $2.25 in cash plus $0.50 in ViroPharma common stock. The deal price represents a premium of 49 percent over Lev's...

  Articles 2008-07-21

• ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs

  EXTON, Pa., July 8 /PRNewswire-FirstCall/ -- ViroPharma Incorporated has been informed by U.S. Food and Drug Administration FDA that the July 23, 2008 meeting of its Advisory Committee for Pharmaceutical Science and Clinical Pharmacology is not intended to discuss specifically ViroPharma's VancocinR vancomycin hydrochloride capsules...

  Articles 2008-07-08

• Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease

  A Complimentary Continuing Education Newsletter Series for Healthcare Professionals VOORHEES, N.J., July 1 /PRNewswire/ -- Clostridium difficile infection CDI is a serious condition that causes disease with a wide spectrum of severity, ranging from mild diarrhea to pseudomembranous colitis and death. Recurrent CDI can...

  Articles 2008-07-01

• Research and Markets: Complete and Comprehensive Analysis of ViroPharma Inc. and Their Competitors

  DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c93803) has announced the addition of "Analysis of ViroPharma Inc." to their offering. We present Analysis of ViroPharma Inc. A complete and comprehensive analysis of ViroPharma Inc. includes an overview of the industry the company operates in, a PEST...

  Articles 2008-06-05

• ViroPharma to Present at the Seventh Annual JMP Securities Research Conference

  EXTON, Pa., May 13 /PRNewswire-FirstCall/ -- ViroPharma Incorporated today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the Seventh Annual JMP Securities Research Conference at 5:00 P.M. ET on Monday, May 19, 2008. The conference is being held at the Ritz-Carlton...

  Articles 2008-05-13

• ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference

  EXTON, Pa., March 13 /PRNewswire-FirstCall/ -- ViroPharma Incorporated today announced that Vincent Milano, chief financial officer and chief operating officer of ViroPharma, will present at the Cowen & Company 28th Annual Health Care Conference at 1:40 P.M. ET on Tuesday, March 18, 2008. The conference is being held...

  Articles 2008-03-13

• ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference

  EXTON, Pa., Feb. 28 /PRNewswire-FirstCall/ -- ViroPharma Incorporated today announced it will present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference at 1:30 P.M. ET on Wednesday, March 5, 2008. The conference is being held at The W Hotel, in New York City....

  Articles 2008-02-28

• Zacks Bull and Bear of the Day Highlights: ViroPharma, 3Com Corporation, Guess? and Estee Lauder

  CHICAGO -- Zacks Equity Research highlights ViroPharma (Nasdaq: VPHM) as the Bull of the Day and 3Com Corporation (Nasdaq: COMS) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Guess? Inc. (NYSE: GES) and Estee Lauder Companies (NYSE: EL). Full analysis of all these stocks...

  Articles 2008-02-28

• ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results

  EXTON, Pa., Feb. 27 /PRNewswire-FirstCall/ -- ViroPharma Incorporated reported today its financial results for the fourth quarter and twelve months ended December 31, 2007. Key events since September 30, 2007 include: Development: -- European Orphan Drug Designation received for CamviaTM maribavir; -- Patient...

  Articles 2008-02-27

• Seven Summits Research Releases Alerts on AIG, TXN, CAT, ADSK, and VPHM

  CHICAGO, Feb. 27 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks. Seven Summits Strategic Investments' PriceWatch Alerts are available at http://www.iotogo.com/s/022708B (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's PriceWatch Alerts...

  Articles 2008-02-27

• Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma

  - Michel de Rosen to Continue as Chairman of the Board of Directors; Daniel B. Soland Promoted to Chief Operating Officer - EXTON, Pa., Feb. 26 /PRNewswire-FirstCall/ -- ViroPharma Incorporated announced today that, effective March 31, 2008, Vincent J. Milano will succeed Michel de Rosen as...

  Articles 2008-02-26

• Progressive Review for ViroPharma Incorporated.

  M2 PRESSWIRE-13 February 2008-The SI Report: Progressive Review for ViroPharma IncorporatedC1994-2008 M2 COMMUNICATIONS LTD RDATE:13022008 Streetinvesting.com has now resumed our progressive review of ViroPharma Incorporated (Nasdaq: VPHM) after it traded down less than 1% Tuesday, early in the afternoon...

  Articles 2008-02-13

• Has added ViroPharma Inc. to their watch list.

  M2 PRESSWIRE-13 February 2008-InvestorInstantMessaging: Has added ViroPharma Inc. to their watch list.C1994-2008 M2 COMMUNICATIONS LTD RDATE:13022008 InvestorIM has been created as a tool for the average investor. The idea is simple, a website where the world can communicate. Do you...

  Articles 2008-02-13

• Has added ViroPharma Inc. to their watch list.

  M2 PRESSWIRE-12 February 2008-The Maybach Journal: Has added ViroPharma Inc. to their watch listC1994-2008 M2 COMMUNICATIONS LTD RDATE:12022008 Maybach Financial is a syndicate of financial informants representing a true investing experience. Taking research from financial consultants, brokers, researchers, and...

  Articles 2008-02-12